Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-038524
Filing Date
2011-06-28
Accepted
2011-06-28 19:36:58
Documents
1
Period of Report
2011-06-27

Document Format Files

Seq Description Document Type Size
1 06/27/11 - UNIT PURCHASE rrd316396.html 4  
1 06/27/11 - UNIT PURCHASE rrd316396.xml 4 8553
  Complete submission text file 0001181431-11-038524.txt   10091
Mailing Address 5350 S ROSLYN SUITE 380 ENGLEWOOD CO 80111
Business Address
BATHGATE STEVEN MARK (Reporting) CIK: 0001011938 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52530 | Film No.: 11936991

Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Issuer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)